These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12799229)

  • 1. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.
    Brown MM; Brown GC; Sharma S; Busbee B
    Ophthalmology; 2003 Jun; 110(6):1076-81. PubMed ID: 12799229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reproducibility of ophthalmic utility values.
    Brown GC; Brown MM; Sharma S; Beauchamp G; Hollands H
    Trans Am Ophthalmol Soc; 2001; 99():199-203; discussion 203-4. PubMed ID: 11797307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
    Kobelt G; Jonsson B; Bergström A; Chen E; Lindén C; Alm A
    Acta Ophthalmol Scand; 2006 Jun; 84(3):363-71. PubMed ID: 16704699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.
    Skalicky S; Goldberg I
    J Glaucoma; 2008; 17(7):546-51. PubMed ID: 18854731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility-based estimates of the relative morbidity of visual impairment and angina.
    Nease RF; Whitcup SM; Ellwein LB; Fox G; Littenberg B
    Ophthalmic Epidemiol; 2000 Sep; 7(3):169-85. PubMed ID: 11035553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quality of life associated with presbyopia.
    Luo BP; Brown GC; Luo SC; Brown MM
    Am J Ophthalmol; 2008 Apr; 145(4):618-622. PubMed ID: 18243152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age-related macular degeneration on health status utility values.
    Espallargues M; Czoski-Murray CJ; Bansback NJ; Carlton J; Lewis GM; Hughes LA; Brand CS; Brazier JE
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4016-23. PubMed ID: 16249475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences for diabetic retinopathy health States.
    Szabo SM; Beusterien KM; Pleil AM; Wirostko B; Potter MJ; Tildesley H; Gonder J; Barsdorf A; Levy AR
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3387-94. PubMed ID: 20053977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.
    Clarke PM; Simon J; Cull CA; Holman RR
    Diabetes Care; 2006 Jul; 29(7):1506-11. PubMed ID: 16801570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
    Rotenstreich Y; Fishman GA; Anderson RJ
    Ophthalmology; 2003 Jun; 110(6):1151-8. PubMed ID: 12799240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost utility for penetrating keratoplasty in patients with poor binocular vision.
    Hirneiss C; Neubauer AS; Niedermeier A; Messmer EM; Ulbig M; Kampik A
    Ophthalmology; 2006 Dec; 113(12):2176-80. PubMed ID: 16996598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility assessment among patients with dry eye disease.
    Schiffman RM; Walt JG; Jacobsen G; Doyle JJ; Lebovics G; Sumner W
    Ophthalmology; 2003 Jul; 110(7):1412-9. PubMed ID: 12867401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
    Nutheti R; Keeffe JE; Shamanna BR; Nirmalan PK; Krishnaiah S; Thomas R
    Ophthalmology; 2007 Aug; 114(8):1552-7. PubMed ID: 17678693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
    Nirmalan PK; Tielsch JM; Katz J; Thulasiraj RD; Krishnadas R; Ramakrishnan R; Robin AL
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2308-12. PubMed ID: 15980215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility assessment among patients of primary angle closure/glaucoma in China: a preliminary study.
    Sun X; Zhang S; Wang N; Liang Y; Wang L; Fan S; Sun L
    Br J Ophthalmol; 2009 Jul; 93(7):871-4. PubMed ID: 19208679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.